Passive smoking among children with chronic respiratory disease

A M Butz1, B J Rosenstein

  • 1Johns Hopkins University School of Nursing, Department of Pediatrics, Baltimore, Maryland 21205.

Insights

Children with chronic respiratory diseases face significant passive smoke exposure. Parents of children with asthma and cystic fibrosis modified smoking behaviors post-diagnosis, highlighting the need for healthcare provider intervention.

Area of Science:

  • Pediatrics
  • Environmental Health
  • Respiratory Medicine

Background:

  • Passive smoke exposure is a significant environmental risk factor for respiratory health in children.
  • Children with chronic respiratory diseases may be particularly vulnerable to the adverse effects of secondhand smoke.

Purpose of the Study:

  • To determine the prevalence and sources of passive smoke exposure in children with chronic respiratory diseases.
  • To compare exposure rates and sources between children with asthma, cystic fibrosis, rheumatoid arthritis, and healthy children.

Main Methods:

  • A questionnaire was mailed to parents of children in four groups: asthma, cystic fibrosis, rheumatoid arthritis, and well children.
  • The questionnaire assessed passive smoke exposure at home and/or daycare and parental smoking behaviors.

Main Results:

  • Twenty percent of respondents reported current smoking, with higher rates in cystic fibrosis and rheumatoid arthritis groups.
  • One-third of all surveyed children experienced daily passive smoke exposure at home and/or daycare.
  • Over 80% of parents of children with asthma and cystic fibrosis reported behavior changes regarding smoking post-diagnosis, compared to 40% in non-respiratory groups.

Conclusions:

  • Children with chronic respiratory diseases, especially asthma and cystic fibrosis, are frequently exposed to passive smoke.
  • Parental smoking behavior modification occurs more frequently after a child's diagnosis, suggesting a window for intervention.
  • Healthcare providers should actively inquire about passive smoke exposure in children, particularly those with chronic respiratory conditions.

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...